Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence
Go back to Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence| Abbott Laboratories (NYSE: ABT) | Delayed: 87.83 -0.58 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.41 | 52 Week High | $46.38 | |||
| Open | $88.14 | 52 Week Low | $36.00 | |||
| Day High | $88.59 | P/E | 58.55 | |||
| Day Low | $87.21 | EPS | $1.50 | |||
| Volume | 11,457,992 | |||||
| ALERE, Inc. (NASDAQ: ALR) | Delayed: 1.32 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.32 | 52 Week High | $54.13 | |||
| Open | $10.12 | 52 Week Low | $31.47 | |||
| Day High | $1.32 | P/E | N/A | |||
| Day Low | $1.32 | EPS | $-1.13 | |||
| Volume | 7 | |||||

